Synthesis and pharmacochemical investigation of some novel 1,2,4-4H-triazoles with potential antiviral activity. 1998

S S Papakonstantinou-Garoufalia, and E Tani, and O Todoulou, and A Papadaki-Valiraki, and E Filippatos, and E De Clercq, and P N Kourounakis
Department of Pharmaceutical Chemistry, School of Pharmacy, University of Athens, Greece.

We report the synthesis of some mercaptotriazole derivatives in an effort to discover underlying structural requirements for antiviral activity. A preliminary antiviral study was performed and the contribution of the compounds to free radical processes was investigated. Because lipophilicity influences both biological activity and antioxidant potential we calculated lipophilicity and attempted to correlate this with antioxidant activity. Treatment of the N-(aryl)piperazineacetohydrazides (compounds 1) with 2,4-dichlorophenylisothiocyanate gave the N-(aryl)piperazinethiosemicarbazides (compounds 2) in good yield. Cyclization of these compounds after treatment with NaOH solution provided the corresponding 5-(4-aryl-1-piperazinylmethyl)-4-(2,4-dichlorophenyl)-4H-1,2,4-triazole- 3-thiols (compounds 3) in good yield. Reaction of compounds 3 with 2,4-dichloro- or 4-fluorobenzyl chloride in acetone in the presence of potassium carbonate gave the target compounds (compounds 4) in about 70% yield. The antioxidant effect of the compounds on non-enzymatic lipid peroxidation of rat hepatic microsomal membranes was studied. Most of the examined compounds were active at concentration of 0.1 mM and most were found to prevent dimethylsulphoxide oxidation moderately (20-50%) at a concentration tenfold less than that of dimethylsulphoxide. The interaction of the synthesized compounds with 1,1-diphenyl-2-picrylhydrazyl stable free radical was also studied. Correlation was found between the two expressions of calculated lipophilicity, antioxidant activity and the lipophilicity of the synthesized compounds, and a correlation was derived between antioxidant activity and delta logP, which expresses the compounds' hydrogen-bonding capacity.

UI MeSH Term Description Entries
D008297 Male Males
D008862 Microsomes, Liver Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough. Liver Microsomes,Liver Microsome,Microsome, Liver
D011916 Rats, Inbred F344 An inbred strain of rat that is used for general BIOMEDICAL RESEARCH purposes. Fischer Rats,Rats, Inbred CDF,Rats, Inbred Fischer 344,Rats, F344,Rats, Inbred Fisher 344,CDF Rat, Inbred,CDF Rats, Inbred,F344 Rat,F344 Rat, Inbred,F344 Rats,F344 Rats, Inbred,Inbred CDF Rat,Inbred CDF Rats,Inbred F344 Rat,Inbred F344 Rats,Rat, F344,Rat, Inbred CDF,Rat, Inbred F344,Rats, Fischer
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D014230 Triazoles Heterocyclic compounds containing a five-membered ring with two carbon atoms and three nitrogen atoms with the molecular formula C2H3N3. Triazole
D015227 Lipid Peroxidation Peroxidase catalyzed oxidation of lipids using hydrogen peroxide as an electron acceptor. Lipid Peroxidations,Peroxidation, Lipid,Peroxidations, Lipid
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

S S Papakonstantinou-Garoufalia, and E Tani, and O Todoulou, and A Papadaki-Valiraki, and E Filippatos, and E De Clercq, and P N Kourounakis
January 1983, Acta pharmaceutica Suecica,
S S Papakonstantinou-Garoufalia, and E Tani, and O Todoulou, and A Papadaki-Valiraki, and E Filippatos, and E De Clercq, and P N Kourounakis
January 1987, Acta pharmaceutica Suecica,
S S Papakonstantinou-Garoufalia, and E Tani, and O Todoulou, and A Papadaki-Valiraki, and E Filippatos, and E De Clercq, and P N Kourounakis
January 2011, Arzneimittel-Forschung,
S S Papakonstantinou-Garoufalia, and E Tani, and O Todoulou, and A Papadaki-Valiraki, and E Filippatos, and E De Clercq, and P N Kourounakis
January 1983, Acta pharmaceutica Suecica,
S S Papakonstantinou-Garoufalia, and E Tani, and O Todoulou, and A Papadaki-Valiraki, and E Filippatos, and E De Clercq, and P N Kourounakis
October 2000, Archiv der Pharmazie,
S S Papakonstantinou-Garoufalia, and E Tani, and O Todoulou, and A Papadaki-Valiraki, and E Filippatos, and E De Clercq, and P N Kourounakis
January 2010, Iranian journal of pharmaceutical research : IJPR,
S S Papakonstantinou-Garoufalia, and E Tani, and O Todoulou, and A Papadaki-Valiraki, and E Filippatos, and E De Clercq, and P N Kourounakis
November 2008, Archiv der Pharmazie,
S S Papakonstantinou-Garoufalia, and E Tani, and O Todoulou, and A Papadaki-Valiraki, and E Filippatos, and E De Clercq, and P N Kourounakis
September 2016, Acta poloniae pharmaceutica,
S S Papakonstantinou-Garoufalia, and E Tani, and O Todoulou, and A Papadaki-Valiraki, and E Filippatos, and E De Clercq, and P N Kourounakis
October 1989, Ceskoslovenska farmacie,
S S Papakonstantinou-Garoufalia, and E Tani, and O Todoulou, and A Papadaki-Valiraki, and E Filippatos, and E De Clercq, and P N Kourounakis
October 2014, European journal of medicinal chemistry,
Copied contents to your clipboard!